Lv6
1900 积分 2021-06-18 加入
Chinese innovative drug R&D trends in 2024
3个月前
已完结
Kinase-targeted cancer therapies: progress, challenges and future directions
3个月前
已完结
Discovery of a novel BTK inhibitor S-016 and identification of a new strategy for the treatment of lymphomas including BTK inhibitor-resistant lymphomas
3个月前
已完结
Zanubrutinib: past, present, and future
3个月前
已完结
Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies
3个月前
已完结
Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advances
3个月前
已完结
An overview of kinase downregulators and recent advances in discovery approaches
3个月前
已完结
Kinase drug discovery 20 years after imatinib: progress and future directions
3个月前
已完结
Recent insights into the therapeutic strategies targeting the pseudokinase PTK7 in cancer
3个月前
已完结
Kinase Drug Discovery: Modern Approaches
3个月前
已完结
皖公网安备34019202002308
